The Tobacco Regulatory Science Program (TRSP) is an interagency partnership between the NIH and the FDA Center for Tobacco Products to foster tobacco regulatory research.
With the passage of the 2009 Family Smoking Prevention and Tobacco Control Act (Tobacco Control Act), the FDA acquired the authority to regulate the manufacture, marketing, and distribution of tobacco products in order to protect public health. Within the framework of the Tobacco Control Act, the NIH and FDA formed this partnership to establish a comprehensive research agenda in tobacco regulatory science.
- TITLE OF NEW OPPORTUNITY GOES HERE (R01 Clinical Trial Optional)
- FAQs - RFA-OD-19_XXX
- Maximizing the Scientific Value of Existing Biospecimen Collections: Scientific Opportunities for Exploratory Research (R21 Clinical Trial Not Allowed)
- FAQs - RFA-OD-19-021
- Secondary Analyses of Existing Datasets of Tobacco Use and Health (R21 Clinical Trial Not Allowed)
- FAQs - RFA-OD-19-022
TRSP encourages research applications that address the FDA's research priorities to better understand toxicity, addiction, and appeal of tobacco products.
An NIH-FDA partnership to foster tobacco regulatory research.
Research projects on tobacco regulatory research funded through TRSP.
Active funding announcements and application information.
Research topic and project priorities for TRSP funding announcements.
Research tools, publications, statistics, and announcements.